• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159827-76-5)

7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159827-76-5) is a unique and versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of imidazopyridines, which are known for their diverse biological activities and potential therapeutic applications. The presence of a fluorine atom in the molecular structure imparts unique properties that enhance its pharmacological profile, making it a valuable candidate for drug development.

The chemical structure of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid consists of an imidazopyridine core with a fluorine substituent at the 7-position and a carboxylic acid group at the 3-position. This specific arrangement of functional groups confers several advantages, including improved solubility, enhanced metabolic stability, and optimized pharmacokinetic properties. These features are crucial for the development of effective and safe pharmaceuticals.

Recent studies have highlighted the potential of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid in various therapeutic areas. One notable application is in the treatment of neurological disorders. Research has shown that this compound can modulate specific neurotransmitter systems, particularly those involving serotonin and dopamine. This modulation can have beneficial effects on conditions such as depression, anxiety, and neurodegenerative diseases.

In addition to its neurological applications, 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid has also been investigated for its anti-inflammatory properties. In vitro and in vivo studies have demonstrated that this compound can inhibit the production of pro-inflammatory cytokines and reduce oxidative stress. These findings suggest its potential use in treating inflammatory conditions such as arthritis and inflammatory bowel disease.

The pharmacological profile of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid has been further enhanced through structural modifications. For example, the introduction of additional functional groups or changes in the substituent positions can lead to compounds with improved potency and selectivity. This flexibility in chemical design allows researchers to tailor the compound to specific therapeutic targets and optimize its therapeutic index.

Clinical trials involving derivatives of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid have shown promising results. Early-phase trials have demonstrated favorable safety profiles and preliminary evidence of efficacy in treating various conditions. These findings have paved the way for more advanced clinical studies to further evaluate the potential of these compounds as novel therapeutics.

The synthesis of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid is an area of ongoing research. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One common approach involves the condensation of a suitable imidazole derivative with a pyridine carboxylic acid precursor, followed by fluorination at the 7-position. Advances in synthetic chemistry have led to improved yields and purity levels, making it more feasible to produce this compound on a larger scale for research and development purposes.

The biological activity of 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid is not limited to its direct pharmacological effects. It also serves as a valuable tool in chemical biology research. By using this compound as a probe or scaffold, researchers can gain insights into complex biological processes and identify new targets for drug discovery. For example, studies have utilized derivatives of this compound to investigate signaling pathways involved in cell proliferation and apoptosis.

In conclusion, 7-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159827-76-5) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for further investigation and development as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical uses, solidifying its position as an important molecule in modern drug discovery efforts.

• 820245-53-2(Imidazo[1,2-a]pyridine-2-carboxylic acid hydrobromide)
• 367900-94-5(6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 910036-83-8(SODIUM IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLATE HEMIHYDRATE)
• 88751-06-8(5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid)
• 886363-98-0(7-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1020034-56-3(8-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 64951-08-2(Imidazo[1,2-a]pyridine-2-carboxylic acid)
• 6200-60-8(Imidazo[1,2-a]pyridine-3-carboxylic acid)
• 367500-94-5(6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1019021-85-2(6-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid)